On August 27, 2019, in INO Therapeutics LLC v. Praxair Distribution Inc., in a 2-1 decision, the Federal Circuit upheld a district court decision that method-of-treatment claims, comprising excluding certain patients from treatment, were invalid under 35 U.S.C. § 101.

The title above refers to a lyric from a 1998 song by Eve 6, although they used the word "cabinet" instead of "chair." While this simple substitution of a word on my part is designed to evoke an image, the choice of words and the image evoked* can mean so much more in the world of design patents.

Drs. Stephen Quake and Christina Fan ("Quake") appealed a decision of the U.S. Patent and Trademark Office Patent Trial and Appeal Board ("the Board") finding the four claims of Quake's U.S. Patent 8,008,018 and Claim 25 of their U.S. Application No. 12/393,833 unpatentable for lack of written description.

Rob Mattson and Norman Oblon are attending the 2019 AIPPI World Congress conference in London, from September 15-18th. The International Association for the Protection of Intellectual Property, known as the AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world's leading International Organization dedicated to the development and the improvement of laws for the protection of intellectual property.

Stefan Koschmieder will attend the 5th Gulf Chemical and Petrochemicals Association (GCPA) IP Awareness Workshop in Muscat, Oman on September 18-19th.

Oblon professionals took International Guests to a Nationals baseball game at Nats Park in Washington, DC.

Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.

Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.